USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
OpenCell Technologies
Address:
311 Ferst Dr
Atlanta, GA 30332-0390
Phone:
N/A
URL:
N/A
EIN:
273827248
DUNS:
824736610
Number of Employees:
3
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $279,294.00 2
SBIR Phase II $1,008,001.00 1
STTR Phase I $225,000.00 1

Award List:

Electrosonic Ejector Microarray for Development of Cancer Therapies

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$120,586.00
Agency:
HHS
Principal Investigator:
John M. Meacham
Abstract:
DESCRIPTION (provided by applicant): Despite decades of research focused mainly on gene transfection, effective intracellular delivery of biologically relevant material remains a difficult task, inhibiting research in a variety of biological and biomedica l fields. This proposed work describes a… More

Multichannel Electrosonic Actuation Microarray for Cell-Based Screening

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$158,708.00
Agency:
HHS
Principal Investigator:
John M. Meacham
Abstract:
DESCRIPTION (provided by applicant): High-throughput, parallel delivery and transfection of biologically relevant material into cells remains a difficult task. The proposed work addresses this issue through integration of multiple Electrosonic Actuation Mi croarrays (EAMs) into a single MIST… More

Electrosonic Actuation Microarray: High-Throughput Tool for Transfection of Diffi

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$1,008,001.00
Agency:
HHS
Principal Investigator:
John M. Meacham – 404-273-7866
Abstract:
DESCRIPTION (provided by applicant): The ability to introduce drugs, genes, nucleic acids, and/or imaging agents into living cells is critical to drug design and delivery, as well as many cell biology and genetic modification protocols; however, currentlyavailable physical and reagent-based… More

STTR Phase I: Polymer electrosonic actuation microarray: Low-cost tool for transfection of biological cells

Award Year / Program / Phase:
2013 / STTR / Phase I
Award Amount:
$225,000.00
Agency:
NSF
Principal Investigator:
John M. Meacham – (404) 273-7866
Research Institution:
Georgia Tech
RI Contact:
Jonathan Colton
Abstract:
This Small Business Technology Transfer (STTR) Phase I project will prove the technical and commercial feasibility of a single-use polymer microarray for electromechanical transfection of biological cells. Alternative gene transfer solutions are needed to access the potential held in… More